John C. Davis

20.0k citations
216 papers · 10.9k indexed · 6 hit papers · h-index 50

John C. Davis

211 papers receiving 10.3k citations

Hit Papers

Efficacy and safety of golimumab in patients with ankylos...4442002202620102018200400600

Peers

John C. Davis
Comparison fields: 5 of 174
  • Rheumatology 7.0k
  • Hematology 2.3k
  • Immunology 4.1k
  • Genetics 696
  • Nephrology 453
Replace Ricardo Blanco with:
Ricardo Blanco Spain
D Alarcón-Segovia Mexico
Pierre Miossec France
Stefano Bombardieri Italy
Matthias Schneider Germany
Tsuneyo Mimori Japan
Andrea Doria Italy
Graham R.V. Hughes United Kingdom
Gary S. Gilkeson United States
Naomi F. Rothfield United States
John C. Davis relative to Ricardo Blanco Spain Ricardo Blanco's profile →
Citations per field
00.5×1.5×
Ricardo Blanco · 1×
Citations per year

Countries citing papers authored by John C. Davis

Since Specialization
Citations

This map shows the geographic impact of John C. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Davis more than expected).

Fields of papers citing papers by John C. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Davis. The network helps show where John C. Davis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John C. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John C. Davis Line = papers co-authored together John C. Davis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201224
2 201139
3 201148
4 201034
5 200997
6 200833
7
Il-23r is a major determinant of ankylosing spondylitis risk - The tasc study
20077
8 2007145
9 200747
10 200620
11 200589
12 20052
13 2005140
14 200510
15 200441
16 2001352
17 198738
18
High angular resolution stellar interferometry : proceedings of Colloquium no.50 IAU, held at The University of maryland, College Park, Maryland, U.S.A., 30 August - 1 September, 1978
19797
19 19668
20 196213

About John C. Davis

John C. Davis is a scholar working on Rheumatology, Hematology, Nephrology, Reproductive Medicine and Clinical Biochemistry, having authored 216 papers that have together received 10.9k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (45 papers), Rheumatoid Arthritis Research and Therapies (39 papers), Autoimmune and Inflammatory Disorders Research (25 papers), Vasculitis and related conditions (21 papers), Systemic Lupus Erythematosus Research (18 papers), Sarcoidosis and Beryllium Toxicity Research (13 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). The work is most often cited by research in Rheumatology (7.0k citations), Hematology (2.3k citations), Immunology (4.1k citations), Genetics (696 citations) and Nephrology (453 citations). John C. Davis has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Désirée van der Heijde, Jürgen Braun, Joachim Sieper, Jennifer D. Gorman, Kenneth E. Sack, John D. Reveille, Maxime Dougados, Robert Landewé, S van der Linden and H. L. Sheehan. Their work appears in journals such as Annals of the Rheumatic Diseases, The Lancet, Blood, Arthritis Care & Research and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026